Concepedia

Srikanth C. Nallani

SC

Statistics

Publications

11

Citations

779

H-Index

11

Active since

2001

Affiliations

University of Cincinnati Medical Center(Current)

University of Cincinnati

Center for Drug Evaluation and Research

University of Washington

United States Food and Drug Administration

Srikanth C. Nallani is an author at University of Cincinnati Medical Center specializing in pharmacology, induction in hepatocytes, and medicine.

ORCID

Publications per year

2001–2024

11

Publications

11

Induction of CYP3A4 by Efavirenz in Primary Human Hepatocytes: Comparison With Rifampin and Phenobarbital

Niresh Hariparsad, Srikanth C. Nallani, Rucha Sane et al. · The Journal of Clinical Pharmacology · 2004 · 189 citations

, , +13

Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen

Pankaj B. Desai, Srikanth C. Nallani, Rucha Sane et al. · Drug Metabolism and Disposition · 2002 · 118 citations

, , +17

Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19

Alice Ke, Srikanth C. Nallani, Ping Zhao et al. · British Journal of Clinical Pharmacology · 2013 · 112 citations · Full text

, , +17

A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women

Alice Ke, Srikanth C. Nallani, Ping Zhao et al. · Drug Metabolism and Disposition · 2013 · 87 citations · Full text

, , +17

Dose‐dependent Induction of Cytochrome P450 (CYP) 3A4 and Activation of Pregnane X Receptor by Topiramate

Srikanth C. Nallani, Tracy A. Glauser, Niresh Hariparsad et al. · Epilepsia · 2003 · 75 citations

, , +16

1–5 of 11